It was found that depletion of TRAF3 upregulated MHC-I through the NF-κB pathway and TRAF3 small molecule inhibitors increased immuno-sensitivity of cancer cells specifically through MHC-I expression. The gene discussed is TRAF3; the disease is cancer.